Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
11-2016 | 08-2016 | 05-2016 | 03-2016 | 02-2016 | |
Sales | 1 | 3 | 2 | 2 | 0 |
Cost of Goods | N/A | N/A | N/A | N/A | 2 |
Gross Profit | 1 | 3 | 2 | 2 | N/A |
Operating Expenses | 1,895 | 1,891 | 2,278 | 435 | 0 |
Operating Income | -1,894 | -1,889 | -2,276 | -433 | N/A |
Interest Expense | 1 | 2 | 221 | 221 | 0 |
Other Income | 88 | 95 | 71 | -1,772 | 0 |
Pre-tax Income | -1,807 | -1,796 | -2,426 | -2,426 | 0 |
Net Income Continuous | -1,807 | -1,796 | -2,426 | -1,381 | N/A |
Net Income | $-1,807 | $-1,796 | $-2,426 | $-2,426 | $N/A |
EPS Basic Total Ops | -7.96 | -8.14 | -10.71 | -6.24 | N/A |
EPS Basic Continuous Ops | -8.09 | -8.04 | -10.87 | -6.22 | N/A |
EPS Diluted Total Ops | -7.96 | -8.14 | -10.71 | -6.24 | N/A |
EPS Diluted Continuous Ops | -8.09 | -8.04 | -10.87 | -6.22 | N/A |
EBITDA(a) | $-1,447 | $-1,414 | $-1,807 | $47 | $N/A |